Concepedia

Weina Shen

WS

Statistics

Publications

8

Citations

206

H-Index

8

Active since

2007

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Weina Shen is an author at Fudan University Shanghai Cancer Center specializing in radiation oncology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2007–2024

8

Publications

8

Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

Jian Zhang, Dongmei Ji, Weina Shen et al. · Clinical Cancer Research · 2022 · 63 citations

The role of sequential 18<sup>F</sup>‐<scp>FDG PET</scp>/<scp>CT</scp> in predicting tumour response after preoperative chemoradiation for rectal cancer

Wenjie Sun, Jianmin Xu, Wei Hu et al. · Colorectal Disease · 2013 · 31 citations

Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials.

Sara A. Hurvitz, Haeseong Park, Sophia Frentzas et al. · Journal of Clinical Oncology · 2021 · 22 citations

, , +17

Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial

Shasha Chen, Weina Shen, Yuhuan Liu et al. · Chinese Medical Journal · 2023 · 22 citations · Full text

Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial

Panpan Zhang, Si Shi, Jianming Xu et al. · European Journal of Cancer · 2024 · 19 citations · Full text

1–5 of 8